Evoke Wealth’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-1
Closed 1056
2022
Q3
$0 Hold
1
﹤0.01% 1264
2022
Q2
$0 Buy
+1
New +$42 ﹤0.01% 1247
2022
Q1
Sell
-170
Closed -$16K 1250
2021
Q4
$16K Sell
170
-453
-73% -$54.1K ﹤0.01% 718
2021
Q3
$79K Sell
623
-2
-0.3% -$291 ﹤0.01% 455
2021
Q2
$104K Sell
625
-7,203
-92% -$1.17M ﹤0.01% 434
2021
Q1
$1.42M Buy
7,828
+7,356
+1,558% +$1.71M 0.06% 130
2020
Q4
$94K Buy
472
+455
+2,676% +$92.5K 0.01% 306
2020
Q3
$4K Hold
17
﹤0.01% 737
2020
Q2
$3K Buy
+17
New +$2.98K ﹤0.01% 819

Other funds holding TDOC

Evoke Wealth's TDOC Position: Q4 2022 in Review

Evoke Wealth sold out of Teladoc Health (TDOC) in Q4 2022, closing a stake of 1 share.

Evoke Wealth first reported a position in TDOC in Q2 2020 and held it in 9 quarters. The position peaked at $1.42M in Q1 2021. 445 funds tracked by Wall St. Rank hold TDOC as of Q4 2022.

  • Evoke Wealth reported no remaining Teladoc Health position as of Q4 2022 after selling out during the quarter.
  • Evoke Wealth sold 1 Teladoc Health share in Q4 2022.
  • Evoke Wealth first reported a position in Teladoc Health in Q2 2020 and held it in 9 quarters.
  • Evoke Wealth's Teladoc Health position peaked at $1.42M in Q1 2021.
  • 445 funds tracked by Wall St. Rank held Teladoc Health as of Q4 2022.

Based on Evoke Wealth's 13F filing for Q4 2022, filed 10 Feb 2023.